000 01686 a2200445 4500
005 20250514070620.0
264 0 _c20030618
008 200306s 0 0 eng d
022 _a0270-9139
024 7 _a10.1053/jhep.2003.50228
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPérez, María José
245 0 0 _aProteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cJun 2003
300 _a1395-404 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aArachidonic Acid
_xpoisoning
650 0 4 _aButhionine Sulfoximine
_xpoisoning
650 0 4 _aCarcinoma, Hepatocellular
_xpathology
650 0 4 _aCysteine Endopeptidases
_xphysiology
650 0 4 _aCytochrome P-450 CYP2E1
_xmetabolism
650 0 4 _aDrug Synergism
650 0 4 _aEndopeptidases
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIron
_xpoisoning
650 0 4 _aLeupeptins
_xpharmacology
650 0 4 _aLipid Peroxides
_xmetabolism
650 0 4 _aLiver Neoplasms
_xpathology
650 0 4 _aLysosomes
_xenzymology
650 0 4 _aMembrane Potentials
_xdrug effects
650 0 4 _aMitochondria, Liver
_xphysiology
650 0 4 _aMultienzyme Complexes
_xantagonists & inhibitors
650 0 4 _aProteasome Endopeptidase Complex
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTyrosine
_xanalogs & derivatives
700 1 _aCederbaum, Arthur I
773 0 _tHepatology (Baltimore, Md.)
_gvol. 37
_gno. 6
_gp. 1395-404
856 4 0 _uhttps://doi.org/10.1053/jhep.2003.50228
_zAvailable from publisher's website
999 _c12560223
_d12560223